Ovid Therapeutics Inc. Common Stock, Value, Issued
Ovid Therapeutics Inc. (OVID) had Common Stock, Value, Issued of $185.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-13
- 2026-06-30: Common Stock, Value, Issued $185.00K.
- 2026-03-31: Common Stock, Value, Issued $167.00K.
- 2025-12-31: Common Stock, Value, Issued $130.00K.
- 2025-09-30: Common Stock, Value, Issued $71.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $185.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $167.00K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $130.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $71.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $71.00K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $71.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $71.00K 10-K · filed 2026-03-18 | |
| 2024-09-30 | $71.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $71.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $71.00K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $71.00K 10-K · filed 2025-03-11 | $70.69K 10-K · filed 2024-03-08 |
| 2023-09-30 | $70.68K 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $70.60K 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $70.49K 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $70.47K 10-K · filed 2024-03-08 | |
| 2022-09-30 | $70.47K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $70.41K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $70.37K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $70.36K 10-K · filed 2023-03-13 | |
| 2021-09-30 | $68.02K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $67.83K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $67.79K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $65.74K 10-K · filed 2022-03-15 | |
| 2020-09-30 | $63.44K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $57.08K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $54.75K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $54.71K 10-K · filed 2021-03-15 | |
| 2019-09-30 | $37.47K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $38.69K 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $38.69K 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $24.65K 10-K · filed 2020-03-11 | |
| 2018-09-30 | $24.65K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $24.63K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $24.62K 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $24.61K 10-K · filed 2019-03-07 | |
| 2017-09-30 | $24.60K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $24.60K 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $9.84K 10-Q · filed 2017-06-13 | |
| 2016-12-31 | $9.84K 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |